Association of Thyroid Dysfunction With Cognitive Function: An Individual Participant Data Analysis
- PMID: 34491268
- PMCID: PMC8424529
- DOI: 10.1001/jamainternmed.2021.5078
Association of Thyroid Dysfunction With Cognitive Function: An Individual Participant Data Analysis
Abstract
Importance: In clinical guidelines, overt and subclinical thyroid dysfunction are mentioned as causal and treatable factors for cognitive decline. However, the scientific literature on these associations shows inconsistent findings.
Objective: To assess cross-sectional and longitudinal associations of baseline thyroid dysfunction with cognitive function and dementia.
Design, setting, and participants: This multicohort individual participant data analysis assessed 114 267 person-years (median, 1.7-11.3 years) of follow-up for cognitive function and 525 222 person-years (median, 3.8-15.3 years) for dementia between 1989 and 2017. Analyses on cognitive function included 21 cohorts comprising 38 144 participants. Analyses on dementia included eight cohorts with a total of 2033 cases with dementia and 44 573 controls. Data analysis was performed from December 2016 to January 2021.
Exposures: Thyroid function was classified as overt hyperthyroidism, subclinical hyperthyroidism, euthyroidism, subclinical hypothyroidism, and overt hypothyroidism based on uniform thyrotropin cutoff values and study-specific free thyroxine values.
Main outcomes and measures: The primary outcome was global cognitive function, mostly measured using the Mini-Mental State Examination. Executive function, memory, and dementia were secondary outcomes. Analyses were first performed at study level using multivariable linear regression and multivariable Cox regression, respectively. The studies were combined with restricted maximum likelihood meta-analysis. To overcome the use of different scales, results were transformed to standardized mean differences. For incident dementia, hazard ratios were calculated.
Results: Among 74 565 total participants, 66 567 (89.3%) participants had normal thyroid function, 577 (0.8%) had overt hyperthyroidism, 2557 (3.4%) had subclinical hyperthyroidism, 4167 (5.6%) had subclinical hypothyroidism, and 697 (0.9%) had overt hypothyroidism. The study-specific median age at baseline varied from 57 to 93 years; 42 847 (57.5%) participants were women. Thyroid dysfunction was not associated with global cognitive function; the largest differences were observed between overt hypothyroidism and euthyroidism-cross-sectionally (-0.06 standardized mean difference in score; 95% CI, -0.20 to 0.08; P = .40) and longitudinally (0.11 standardized mean difference higher decline per year; 95% CI, -0.01 to 0.23; P = .09). No consistent associations were observed between thyroid dysfunction and executive function, memory, or risk of dementia.
Conclusions and relevance: In this individual participant data analysis of more than 74 000 adults, subclinical hypothyroidism and hyperthyroidism were not associated with cognitive function, cognitive decline, or incident dementia. No rigorous conclusions can be drawn regarding the role of overt thyroid dysfunction in risk of dementia. These findings do not support the practice of screening for subclinical thyroid dysfunction in the context of cognitive decline in older adults as recommended in current guidelines.
Conflict of interest statement
Figures
Similar articles
-
Thyrotropin level and cognitive performance: Baseline results from the ELSA-Brasil Study.Psychoneuroendocrinology. 2018 Jan;87:152-158. doi: 10.1016/j.psyneuen.2017.10.017. Epub 2017 Oct 20. Psychoneuroendocrinology. 2018. PMID: 29096222
-
Subclinical thyroid dysfunction and cognitive decline in old age.PLoS One. 2013;8(3):e59199. doi: 10.1371/journal.pone.0059199. Epub 2013 Mar 12. PLoS One. 2013. PMID: 23554996 Free PMC article.
-
The association between subclinical thyroid dysfunction and dementia: The Health, Aging and Body Composition (Health ABC) Study.Clin Endocrinol (Oxf). 2017 Nov;87(5):617-626. doi: 10.1111/cen.13458. Epub 2017 Sep 14. Clin Endocrinol (Oxf). 2017. PMID: 28850708 Free PMC article.
-
Subclinical Thyroid Dysfunction and the Risk of Cognitive Decline: a Meta-Analysis of Prospective Cohort Studies.J Clin Endocrinol Metab. 2016 Dec;101(12):4945-4954. doi: 10.1210/jc.2016-2129. Epub 2016 Sep 30. J Clin Endocrinol Metab. 2016. PMID: 27689250 Free PMC article. Review.
-
Thyroid Function and Cognitive Decline: A Narrative Review.Endocr Pract. 2024 Nov;30(11):1113-1118. doi: 10.1016/j.eprac.2024.07.013. Epub 2024 Aug 5. Endocr Pract. 2024. PMID: 39111592 Review.
Cited by
-
The assessment of psychosocial distress in hospitalized cancer patients during radio-oncological treatment: a monocentric experience study.Support Care Cancer. 2024 Nov 13;32(12):785. doi: 10.1007/s00520-024-08977-3. Support Care Cancer. 2024. PMID: 39535622
-
Subclinical hyperthyroidism and the risk of dementia: A meta-analysis.Brain Behav. 2024 Sep;14(9):e70037. doi: 10.1002/brb3.70037. Brain Behav. 2024. PMID: 39295103 Free PMC article.
-
Olfaction and thyroid hormones in patients with subjective cognitive decline, non-amnestic and amnestic mild cognitive impairment.Wien Klin Wochenschr. 2024 Sep 18. doi: 10.1007/s00508-024-02431-4. Online ahead of print. Wien Klin Wochenschr. 2024. PMID: 39292229
-
Understanding the Complexity of Early-Onset Dementia.Cureus. 2024 Apr 9;16(4):e57897. doi: 10.7759/cureus.57897. eCollection 2024 Apr. Cureus. 2024. PMID: 38725758 Free PMC article.
-
Capsiate ameliorates secondary hyperparathyroidism by improving insulin sensitivity and inhibiting angiogenesis.J Cell Mol Med. 2024 Apr;28(8):e18202. doi: 10.1111/jcmm.18202. J Cell Mol Med. 2024. PMID: 38591872 Free PMC article.
References
-
- Cognitive Decline Partnership Centre . Clinical practice guidelines and principles for people with dementia. Published February 2016. Accessed August 2, 2021. https://cdpc.sydney.edu.au/research/clinical-guidelines-for-dementia/
